Matches in SemOpenAlex for { <https://semopenalex.org/work/W543922> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W543922 endingPage "352" @default.
- W543922 startingPage "346" @default.
- W543922 abstract "To study the visual outcomes and change in central macular thickness (CMT) in patients with neovascular age-related macular degeneration (AMD) who were previously treated with ranibizumab (Lucentis) and/or bevacizumab (Avastin) and were subsequently switched to aflibercept (VEGF Trap-Eye; Eylea).Retrospective study of patients who received intravitreal aflibercept from December 2011 to December 2012 and had previous anti-vascular endothelial growth factor treatment for AMD. The main outcome measures were best-corrected visual acuity (BCVA) and CMT as measured by optical coherence tomography.The study population included 30 patients aged 80.4±1.45 (mean±SEM) who received 6.27±0.37 (range 4-11) aflibercept injections. Eighteen patients had previously received only bevacizumab (12.4±2.18 injections), 2 had received only ranibizumab (19±6 injections), and 10 had received both ranibizumab and bevacizumab (mean 19.3 injections). BCVA logMAR at the initial visit (aflibercept initiation) was 0.506±0.054 (mean VA 20/64), and then, follow ups at 1-month 0.504±0.055 (20/64) P=0.903, 3-months 0.458±0.061 (20/57) P=0.112, 6-months 0.413±0.071 (20/52) P=0.036, and 12-months 0.521±0.076 (20/66) P=0.836. CMT at the initial visit was 261±10.9, and then, at 1-month 238±12.4 P=0.021, 3-months 245±10.6 P=0.102, 6-months 245±10.4 P=0.099, and 12-months 237±10.2 P=0.012. Results were similar in a subset of patients (n=15) with central macular edema or submacular fluid at aflibercept initiation. While on aflibercept, 2 patients developed intraocular pressure increases that required treatment.These findings demonstrate a significant decrease in CMT but no statistically significant improvement in BCVA through the 12-month follow up in patients previously treated who were switched to aflibercept for AMD. Patients may develop ocular hypertension after multiple aflibercept injections." @default.
- W543922 created "2016-06-24" @default.
- W543922 creator A5043491487 @default.
- W543922 creator A5050030287 @default.
- W543922 creator A5067288250 @default.
- W543922 creator A5072692487 @default.
- W543922 date "2014-05-01" @default.
- W543922 modified "2023-09-27" @default.
- W543922 title "Aflibercept in the Treatment of Neovascular Age-Related Macular Degeneration in Previously Treated Patients" @default.
- W543922 cites W1500728559 @default.
- W543922 cites W1789824814 @default.
- W543922 cites W1964901573 @default.
- W543922 cites W1993949890 @default.
- W543922 cites W1997375453 @default.
- W543922 cites W2001280964 @default.
- W543922 cites W2004117352 @default.
- W543922 cites W2012225016 @default.
- W543922 cites W2024806987 @default.
- W543922 cites W2029406931 @default.
- W543922 cites W2048685120 @default.
- W543922 cites W2049577742 @default.
- W543922 cites W2055822421 @default.
- W543922 cites W2079111025 @default.
- W543922 cites W2084462826 @default.
- W543922 cites W2112069706 @default.
- W543922 cites W2143874967 @default.
- W543922 cites W2156799887 @default.
- W543922 cites W2498794671 @default.
- W543922 cites W2067063190 @default.
- W543922 doi "https://doi.org/10.1089/jop.2013.0188" @default.
- W543922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24552305" @default.
- W543922 hasPublicationYear "2014" @default.
- W543922 type Work @default.
- W543922 sameAs 543922 @default.
- W543922 citedByCount "20" @default.
- W543922 countsByYear W5439222015 @default.
- W543922 countsByYear W5439222016 @default.
- W543922 countsByYear W5439222017 @default.
- W543922 countsByYear W5439222018 @default.
- W543922 countsByYear W5439222019 @default.
- W543922 countsByYear W5439222021 @default.
- W543922 countsByYear W5439222022 @default.
- W543922 crossrefType "journal-article" @default.
- W543922 hasAuthorship W543922A5043491487 @default.
- W543922 hasAuthorship W543922A5050030287 @default.
- W543922 hasAuthorship W543922A5067288250 @default.
- W543922 hasAuthorship W543922A5072692487 @default.
- W543922 hasConcept C118487528 @default.
- W543922 hasConcept C141071460 @default.
- W543922 hasConcept C167135981 @default.
- W543922 hasConcept C2776403814 @default.
- W543922 hasConcept C2776694085 @default.
- W543922 hasConcept C2777802072 @default.
- W543922 hasConcept C2778257484 @default.
- W543922 hasConcept C2778749236 @default.
- W543922 hasConcept C2781100027 @default.
- W543922 hasConcept C2908647359 @default.
- W543922 hasConcept C71924100 @default.
- W543922 hasConcept C99454951 @default.
- W543922 hasConceptScore W543922C118487528 @default.
- W543922 hasConceptScore W543922C141071460 @default.
- W543922 hasConceptScore W543922C167135981 @default.
- W543922 hasConceptScore W543922C2776403814 @default.
- W543922 hasConceptScore W543922C2776694085 @default.
- W543922 hasConceptScore W543922C2777802072 @default.
- W543922 hasConceptScore W543922C2778257484 @default.
- W543922 hasConceptScore W543922C2778749236 @default.
- W543922 hasConceptScore W543922C2781100027 @default.
- W543922 hasConceptScore W543922C2908647359 @default.
- W543922 hasConceptScore W543922C71924100 @default.
- W543922 hasConceptScore W543922C99454951 @default.
- W543922 hasIssue "4" @default.
- W543922 hasLocation W5439221 @default.
- W543922 hasLocation W5439222 @default.
- W543922 hasOpenAccess W543922 @default.
- W543922 hasPrimaryLocation W5439221 @default.
- W543922 hasRelatedWork W1995044506 @default.
- W543922 hasRelatedWork W2015993450 @default.
- W543922 hasRelatedWork W2049577742 @default.
- W543922 hasRelatedWork W2123096760 @default.
- W543922 hasRelatedWork W2320987231 @default.
- W543922 hasRelatedWork W2553987180 @default.
- W543922 hasRelatedWork W2559118752 @default.
- W543922 hasRelatedWork W2577193304 @default.
- W543922 hasRelatedWork W2745923716 @default.
- W543922 hasRelatedWork W4243304339 @default.
- W543922 hasVolume "30" @default.
- W543922 isParatext "false" @default.
- W543922 isRetracted "false" @default.
- W543922 magId "543922" @default.
- W543922 workType "article" @default.